Causes of BPH: Risk Factors & Pathophysiology of Enlarged Prostate

What causes BPH? – Overview

Benign Prostatic Hyperplasia (BPH) is a complex condition with multiple contributing factors. The fundamental cause is aging – BPH does not occur in young men. However, aging alone does not explain why some men develop severe BPH while others have minimal enlargement.

Key factors include:

• Hormonal changes (DHT, estrogen, testosterone)
• Genetic predisposition
• Chronic inflammation
• Lifestyle factors (obesity, diet)
• Metabolic syndrome and diabetes

The role of hormones – testosterone, DHT, and estrogen

Hormonal changes with age are the primary drivers of prostate growth:

Testosterone and DHT (Dihydrotestosterone):

• Testosterone is converted to DHT by the enzyme 5-alpha reductase type 2 within the prostate.
• DHT is 5-10 times more potent than testosterone and is the primary hormone that stimulates prostate cell growth.
• DHT levels in the prostate remain high even as blood testosterone declines with age.
• Evidence: Men with 5-alpha reductase deficiency (genetic) have very small prostates and never develop BPH.

Estrogen:

• As men age, testosterone levels decline, but estrogen levels remain stable or increase (relative estrogen excess).
• Estrogen may sensitise the prostate to DHT, promoting growth.
• Estrogen also induces inflammation in the prostate.

Other hormones:

• Insulin and insulin-like growth factor (IGF-1) – elevated in metabolic syndrome, may promote prostate growth.
• Growth hormone – declines with age; unclear role in BPH.

Genetic factors – heritability and race

Genetics play a significant role in BPH development:

• Heritability: Twin studies suggest 40-50% of BPH risk is genetic.
• Family history: Men with a father or brother who had BPH surgery are at higher risk.
• Race/ethnicity:
  • African‑descent men tend to have larger prostates and develop BPH earlier.
  • Asian men tend to have smaller prostates and lower BPH rates.
  • White men have intermediate risk.
• Genetic variants: Several gene variants (in the androgen receptor, 5-alpha reductase, and growth factor genes) have been associated with BPH risk, but no single "BPH gene" has been identified.

If you have a strong family history of BPH, you may need to start monitoring for symptoms earlier (age 40-45).

Cellular changes – hyperplasia vs. hypertrophy

BPH involves both hyperplasia (increase in cell number) and hypertrophy (increase in cell size):

• Hyperplasia: The number of epithelial and stromal cells increases. This accounts for most of the volume increase.
• Hypertrophy: Individual cells enlarge, especially in the smooth muscle component.
• Location: BPH occurs primarily in the transitional zone (the area surrounding the urethra). This is why BPH compresses the urethra, causing urinary symptoms.
• Nodular growth: The prostate develops discrete nodules of hyperplastic tissue, not uniform enlargement.

These changes are driven by hormonal signals and growth factors (EGF, FGF, TGF-beta).

Inflammation and BPH – the chronic inflammation link

Chronic inflammation is now recognised as a key driver of BPH progression:

• Prevalence: Up to 80% of BPH surgical specimens show chronic inflammation on pathology.
• Mechanism: Inflammatory cells (lymphocytes, macrophages) release cytokines (IL-8, TNF-alpha) and growth factors that stimulate prostate cell proliferation.
• Triggers:
  • Urinary tract infections
  • Autoimmune reactions
  • Oxidative stress
  • Dietary factors (high-fat diet)
• Clinical correlation: Men with chronic inflammation on biopsy have larger prostates, more severe symptoms, and worse response to medications.

Lifestyle risk factors – obesity, diet, exercise

Modifiable lifestyle factors significantly influence BPH risk:

Obesity:

• Higher BMI is strongly associated with larger prostate volume and worse BPH symptoms.
• Mechanisms: Increased estrogen (from fat tissue), chronic inflammation, insulin resistance.
• Weight loss (even modest) can improve BPH symptoms.

Diet:

• High-fat diet, red meat, processed foods: Linked to higher BPH risk.
• High-fibre diet, fruits, vegetables: Protective effect.
• Lycopene (tomatoes): May reduce BPH progression (stronger evidence for prostate cancer).

Physical activity:

• Regular exercise (150 min/week moderate activity) reduces BPH risk and symptom progression.
• Even walking is beneficial.

Alcohol and smoking:

• Alcohol: Moderate intake not clearly linked; heavy alcohol may worsen nocturia (diuretic effect).
• Smoking: Mixed evidence – some studies show increased risk, others no association. Smoking is harmful for overall health regardless.

Medical conditions linked to BPH

Several medical conditions are associated with higher BPH risk:

• Metabolic syndrome: Combination of obesity, hypertension, insulin resistance, and dyslipidemia – strongly linked to BPH progression.
• Type 2 diabetes: Increases risk of BPH and worsens symptoms (via insulin resistance and inflammation).
• Cardiovascular disease: Shared risk factors (obesity, inflammation).
• Erectile dysfunction: Often co-exists with BPH (shared vascular and hormonal mechanisms).

Managing these conditions may also improve BPH symptoms.

Medications that can worsen BPH symptoms

Certain medications can exacerbate urinary symptoms in men with BPH:

• Decongestants (pseudoephedrine, phenylephrine): Alpha-agonists that tighten the prostate smooth muscle – can cause acute urinary retention.
• Antihistamines (diphenhydramine, Benadryl): Anticholinergic effects can worsen urinary retention and cause constipation.
• Diuretics (hydrochlorothiazide, furosemide): Increase urine output, worsening frequency and nocturia.
• Calcium channel blockers (nifedipine, amlodipine): May affect bladder contractility.
• Tricyclic antidepressants (amitriptyline): Anticholinergic effects.
• Opioid pain medications: Can cause urinary retention (especially in elderly).

Pathophysiology summary – how enlargement causes symptoms

The enlarged prostate causes symptoms through two mechanisms:

• Mechanical obstruction: The enlarged prostate compresses the urethra, physically blocking urine flow. This causes voiding symptoms (weak stream, hesitancy, straining).
• Dynamic obstruction: The smooth muscle of the prostate and bladder neck contains alpha-1 adrenergic receptors. When stimulated (by stress, cold, or medications), these muscles contract, worsening obstruction. This explains why alpha-blockers (tamsulosin) relax the muscle and improve flow.
• Secondary bladder changes: Chronic obstruction causes the bladder muscle to thicken (hypertrophy), leading to overactivity (urgency, frequency) and eventually weakness (incomplete emptying, retention).

What DOES NOT cause BPH – debunking myths

• Myth: "Frequent ejaculation causes BPH."
  ➜ Fact: No evidence. Some studies suggest frequent ejaculation may reduce BPH risk.
• Myth: "BPH is caused by prostate cancer."
  ➜ Fact: BPH and cancer are separate conditions. BPH does not turn into cancer.
• Myth: "Vasectomy causes BPH."
  ➜ Fact: No association. Large studies have disproven this.
• Myth: "Cycling causes BPH."
  ➜ Fact: Cycling may worsen perineal discomfort but does not cause prostate enlargement.
• Myth: "Low testosterone prevents BPH."
  ➜ Fact: Men with low testosterone can still develop BPH (other factors at play).

Interactive FAQ – Causes of BPH

---

Disclaimer: This information is for educational purposes. If you have BPH symptoms, discuss risk factors and treatment options with a urologist at Vivekananda Hospital.